by | Jun 6, 2024 | Cannabis research
CAPS Trial: Cannabidiol Youth Anxiety Pilot Study (open-label completed, 2020) This study ran for 12 weeks and involved 31 participants aged 12-25 who were diagnosed with severe anxiety disorders and failed to respond to cognitive behavioural therapy (CBT) sessions,...
by | Apr 3, 2023 | Cannabis research
Women experience a sharp fall in oestrogen levels at around the age of 50, which can contribute to weight gain, cardiometabolic illness, osteoporosis, gastrointestinal issues, and cognitive decline. Hormone replacement therapy (HRT) is one of the few therapeutic...
by | Mar 16, 2023 | Cannabis research
A recent study on the effects of a cannabis oil in children with Autism Spectrum Disorder (ASD), has shown promising results with 93% of participants reporting positive effects after 4 weeks. The trial was conducted by Professor Michael Fahey at Monash Children’s...
by | Mar 16, 2023 | Cannabis research
Orygen, The National Centre for Excellence in Youth Mental Health and Lambert Initiative for Cannabinoid Therapeutics teamed up to study the effects of CBD in Australian young people, particularly on the treatment-resistant anxiety. CBD, or cannabidiol is a...
by | Sep 5, 2022 | Cannabis research
In March 2022, the Michael J Fox Foundation published a guide for Medicinal Cannabis and Parkinson’s disease (PD). Michael J Fox, the iconic actor best known for his role as Marty McFly role in the Back to the Future series, disclosed his 1991 Parkinson’s diagnosis,...
by | Mar 24, 2021 | Cannabis research
Researchers from Ben-Gurion University (BGU) and the Soroka University Medical Centre have released a new study exploring the effect of medical cannabis as treatment in hypertension patients 60 years old and above. The study, published in the European Journal of...
